Articles

Synthesis of 6-Alkoxyl-2-propylthio-8-azapurine Nucleosides and Their Antiplatelet Aggregation Activity Evaluation

  • Deng Conger ,
  • Li Shunlai ,
  • Liu Xiangwei ,
  • Du Hongguang
Expand
  • College of Science, Beijing University of Chemical Technology, Beijing 100029

Received date: 2013-03-11

  Revised date: 2013-04-04

  Online published: 2013-04-17

Supported by

Project supported by the National Natural Science Foundation of China (No. 21272022).

Abstract

2-Thiobarbituric acid (1) was converted to 4,6-dichloro-5-nitro-2-propylthiopyrimidine (4) via S-alkylation, nitration and chlorination. Followed by azide and reduction reaction of azido, 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose (5) was converted to 1-amino-2,3,5-tri-O-benzoyl-β-D-ribofuranose (7). 9-[(2',3',5'-Tri-O-benzoyl)-β-D-ribofuranosyl]-6-chloro-2-propylthio-8-azapurine (10) was obtained via nucleophilic substitution of 7 with 4, reduction, diazotization and coupling reaction. Nucleophilic displacement of the chloride in 10 with various alcohols and deprotection afforded 6-alkoxyl-2-propylthio-8-azapurine nucleosides (11). Their structures were identified by 1H NMR, 13C NMR, IR and HRMS techniques. Moreover, the antiplatelet aggregation activities of compounds 11 were measured.

Cite this article

Deng Conger , Li Shunlai , Liu Xiangwei , Du Hongguang . Synthesis of 6-Alkoxyl-2-propylthio-8-azapurine Nucleosides and Their Antiplatelet Aggregation Activity Evaluation[J]. Chinese Journal of Organic Chemistry, 2013 , 33(08) : 1741 -1748 . DOI: 10.6023/cjoc201303017

References

[1] Jennings, L. K. Am. J. Cardiol. 2009, 103, 4A.
[2] Awtry, E. H.; Loscalzo, J. Circulation 2000, 101, 1206.
[3] Cattaneo, M. Drug News Perspect 2006, 19, 253.
[4] James, E.; David, E.; Cindy, L. Circulation 2003, 108, 1316.
[5] Aerschot, A.; Mamos, P.; Weyns, J. J. Med. Chem. 1993, 36, 2938.
[6] Sagi, G.; Otvos, L.; Ikeda, S. J. Med. Chem. 1994, 37, 1307.
[7] Smith, W. C.; Sidwell, W. R.; Robins, K. R. J. Med. Chem. 1972, 15, 883.
[8] Montgomery, A. J.; Thomas, J. H. J. Med. Chem. 1972, 15, 305.
[9] Matsuda, A.; Shinozaki, M.; Yamaguchi, T. J. Med. Chem. 1992, 35, 241.
[10] Estep, G. K.; Josef, A. K.; Bacon, R. E. J. Med. Chem. 1995, 38, 2582.
[11] Cox, D.; Ingall, A.; Willis, P. WO 9703084, 1997[Chem. Abstr. 1997, 126, 186328].
[12] Zhang, H. C.; Maryanoff, B. E.; Ye, H.; Chen, C. L. WO 2008054795, 2008[Chem. Abstr. 2008, 148, 517743].
[13] Ding, Z. R.; Kim, S.; Kunapuli, S. P. Mol. Pharm. 2005, 69, 338.
[14] Wu, Z. J.; Li, S. L.; Ding, Z. R.; Du, H. G. Chin. J. Org. Chem. 2011, 31, 1618 (in Chinese).
(吴兆军, 李顺来, 丁忠仁, 杜洪光, 有机化学, 2011, 31, 1618.)
[15] He, Q. W.; Du, H. G. Chin. J. Org. Chem. 2012, 32, 1678 (in Chinese).
(何琦文, 杜洪光, 有机化学, 2012, 32, 1678.)
[16] Du, H. G.; Chen, L.; Wang, S. M. CN 102250097, 2011[Chem. Abstr. 2011, 155, 683474].
[17] Bonnert, R.; Ingall, A.; Springthorpe, B.; Willis, P. WO 9828300, 1998[Chem. Abstr. 1998, 129, 95506].
[18] Storer, R.; Gosselin, G.; Griffon, J. F.; Pierra, C. WO 2007144686, 2006[Chem. Abstr. 2006, 148, 79268].
[19] Volpini, R.; Marucci, G.; Buccioni, M.; Ben, D. D.; Lambertucci, C.; Lammi, C.; Mishra, R. C.; Thomas, A.; Cristalli, G. ChemMedChem 2011, 6, 1074.
[20] Niedballa, U.; Vorbrüggen, H. J. Org. Chem. 1976, 41, 2084.
Outlines

/